M72/AS01 Tuberculosis Vaccine Remains Efficacious After 3 years
The M72/AS01 vaccine shows efficacy against pulmonary tuberculosis (TB) at 3 years in patients with Mycobacterium tuberculosis infection.
All articles by Zahra Masoud
Pneumococcal Vaccine Needed for Recipients of Solid Organ Transplant
Pneumococcal colonization rates are low in recipients of solid organ transplants, but most of the colonizing serotypes are not included in pneumococcal vaccines.
Rifampin and Isoniazid Is Efficacious in Treatment of Pleural Tuberculosis
As a result of low drug resistance in pleural tuberculosis, treatment regimens of pleural TB may include fewer drugs and maintain appropriate levels of efficaciousness.
High-Dose, Quadrivalent Influenza B Vaccine Is safe and Immunogenic
Compared with the standard-dose influenza vaccine, a high-dose quadrivalent inactivated influenza vaccine, GC3114, may provide a more effective influenza vaccine option for the elderly population.
Serotype Replacement in Childhood Invasive Pneumococcal Disease
Understanding the pneumococcal population dynamics will drive an effective next-generation vaccine design.
Invasive Aspergillosis and Mucromycosis Diagnosed With Real-Time PCR
A new real-time polymerase chain reaction assay shows promise in the noninvasive diagnosis of aspergillosis and mucormycosis.
Prospective Surveillance of Enterovirus D68 Improves Epidemiologic Knowledge
Prospective surveillance of enterovirus D68 is contributing to a better understanding of its epidemiology and should be continued.
Skin Cultures May Aid in Prediction of Bloodstream Infection Pathogens
Staphylococcus aureus and Pseudomonas aeruginosa skin cultures may help to predictthe pathogens involved in bloodstream infections.
Building a Tuberculosis-Free World
The first-ever UN High-Level Meeting on tuberculosis, in September 2018, resolved that ending the disease is a global priority.
Safety and Efficacy of Lefamulin for Treatment of Community-Acquired Pneumonia
A novel antibiotic, lefamulin, may not be inferior to moxifloxacin in efficacy and safety for the treatment of community-acquired bacterial pneumonia.
Next post in Pneumonia
